Clinical, Safety, and Economic Evidence in Radioactive Iodine–Refractory Differentiated Thyroid Cancer: A Systematic Literature Review-Reference-Cited by-同舟云学术

Clinical, Safety, and Economic Evidence in Radioactive Iodine–Refractory Differentiated Thyroid Cancer: A Systematic Literature Review

Author:

Anderson Roger T.¹,Linnehan John E.²,Tongbram Vanita³,Keating Karen⁴,Wirth Lori J.⁵

Affiliation:

1. Department of Public Health Sciences, Penn State College of Medicine, Pennsylvania State University, Hershey, Pennsylvania.

2. Department of Health Economics, Oxford Outcomes, Bethesda, Maryland.

3. Department of Health Economics, Oxford Outcomes, Morristown, New Jersey.

4. Department of Global Health Economics, Outcomes, Reimbursement, and Market Access, Bayer Healthcare Pharmaceuticals, Montville, New Jersey.

5. Department of Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

Reference41 articles.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献